$22.220
+0.851 (+3.83%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
Soll ich Attovia Therapeutics Inc-Aktien kaufen?
Attovia Therapeutics, Inc. is a good buy right now due to its recent successful IPO that raised approximately $289 million, reflecting strong market interest. The stock is currently priced at $20.70, which is significantly lower than the analyst price target of $25, suggesting a potential upside of about 20.5%. Additionally, the forward P/E ratio of 4.81 indicates that the stock may be undervalued compared to future earnings expectations. However, the main risk is the negative net income reported for Q1 2026, which stands at -18.66 million USD, indicating ongoing financial challenges.
ATTO schloss am Tuesday bei $22.22, nachdem der Kurs +3.83% gestiegen ist
Attovia Therapeutics Inc (ATTO) last closed at $22.22, gaining +3.83%. These facts feed the 1-day and 1-week ATTO price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Attovia Therapeutics Inc (ATTO) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Seasonality
Bullish
Saisonalitätsanalyse für ATTO
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.